TP53 and cancer: Other studies in humans (Bond et al, 2004) and mice (Post et al, 2010) suggest that single nucleotide polymorphisms that regulate the levels of the MDM-2 E3 ubiquitin ligase, which in turn regulate p53 levels, can modify the age of onset and penetrance of cancers.